Logo Logo
Switch Language to German

Sequist, L. V.; Anderson, I.; Bauer, T. M.; Demars, N.; Felip, E.; Frost, N.; Harb, W.; Horn, L.; Huber, R. M.; Kudla, A. J.; Lee, J.; Mathews, S.; Mehra, R.; Nieva, J.; Perol, M.; Shepherd, F.; Spira, A. and Czibere, A. (2016): A phase 2 study of seribantumab (MM-121) in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive (HRG plus ), locally advanced or metastatic non-small cell lung cancer (NSCLC). In: Annals of Oncology, Vol. 27

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item